Michael McWilliams, Jr., M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 76 | 2023 | 6770 | 7.490 |
Why?
|
Fee-for-Service Plans | 25 | 2023 | 700 | 5.400 |
Why?
|
Health Expenditures | 31 | 2021 | 2366 | 4.180 |
Why?
|
Cost Savings | 16 | 2020 | 913 | 3.710 |
Why?
|
Medically Uninsured | 9 | 2020 | 836 | 1.800 |
Why?
|
Reimbursement, Incentive | 9 | 2021 | 543 | 1.660 |
Why?
|
Health Services Misuse | 5 | 2019 | 244 | 1.530 |
Why?
|
Patient Protection and Affordable Care Act | 9 | 2020 | 1188 | 1.500 |
Why?
|
Cost Control | 8 | 2020 | 628 | 1.410 |
Why?
|
United States | 94 | 2023 | 72334 | 1.380 |
Why?
|
Quality of Health Care | 10 | 2020 | 4330 | 1.370 |
Why?
|
Reimbursement Mechanisms | 6 | 2019 | 667 | 1.360 |
Why?
|
Risk Adjustment | 8 | 2023 | 600 | 1.310 |
Why?
|
Patient Care | 5 | 2017 | 622 | 1.290 |
Why?
|
Subacute Care | 3 | 2021 | 179 | 1.230 |
Why?
|
Health Facility Merger | 2 | 2020 | 47 | 1.200 |
Why?
|
Commerce | 4 | 2017 | 606 | 1.170 |
Why?
|
Hospital-Physician Joint Ventures | 3 | 2020 | 30 | 1.170 |
Why?
|
Medicare Part C | 7 | 2021 | 334 | 1.050 |
Why?
|
Group Practice | 5 | 2021 | 151 | 1.030 |
Why?
|
Insurance Coverage | 8 | 2021 | 1940 | 1.010 |
Why?
|
Skilled Nursing Facilities | 3 | 2021 | 398 | 0.930 |
Why?
|
Insurance, Health | 10 | 2021 | 2498 | 0.890 |
Why?
|
Physician Incentive Plans | 4 | 2020 | 164 | 0.880 |
Why?
|
Health Services | 4 | 2015 | 752 | 0.870 |
Why?
|
Health Services Research | 5 | 2021 | 1812 | 0.870 |
Why?
|
Ambulatory Care | 4 | 2021 | 2775 | 0.870 |
Why?
|
Patient Readmission | 6 | 2021 | 3270 | 0.810 |
Why?
|
Models, Economic | 2 | 2017 | 716 | 0.780 |
Why?
|
Economics, Hospital | 3 | 2018 | 210 | 0.770 |
Why?
|
Delivery of Health Care | 9 | 2019 | 5336 | 0.760 |
Why?
|
Cost Sharing | 4 | 2021 | 409 | 0.740 |
Why?
|
Medicare Part B | 2 | 2019 | 117 | 0.700 |
Why?
|
Health Status | 6 | 2020 | 4077 | 0.690 |
Why?
|
Physicians | 10 | 2021 | 4591 | 0.690 |
Why?
|
Insurance Claim Review | 9 | 2021 | 741 | 0.690 |
Why?
|
Primary Health Care | 7 | 2021 | 4686 | 0.680 |
Why?
|
Risk Sharing, Financial | 1 | 2019 | 47 | 0.670 |
Why?
|
Negotiating | 2 | 2021 | 150 | 0.670 |
Why?
|
Private Sector | 3 | 2017 | 398 | 0.660 |
Why?
|
Insurance Carriers | 2 | 2021 | 156 | 0.650 |
Why?
|
Quality Indicators, Health Care | 5 | 2020 | 1792 | 0.630 |
Why?
|
Health Care Costs | 8 | 2019 | 3242 | 0.610 |
Why?
|
Hospitalization | 13 | 2021 | 10723 | 0.590 |
Why?
|
Medicare Part D | 2 | 2013 | 355 | 0.580 |
Why?
|
Health Care Surveys | 12 | 2021 | 2426 | 0.560 |
Why?
|
Provider-Sponsored Organizations | 1 | 2016 | 12 | 0.560 |
Why?
|
Poverty | 3 | 2020 | 2698 | 0.520 |
Why?
|
Patient Discharge | 4 | 2021 | 3443 | 0.520 |
Why?
|
Aged | 53 | 2021 | 169289 | 0.520 |
Why?
|
Medication Adherence | 2 | 2017 | 2176 | 0.510 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.500 |
Why?
|
Emergency Service, Hospital | 9 | 2021 | 7879 | 0.500 |
Why?
|
Health Care Sector | 1 | 2017 | 195 | 0.490 |
Why?
|
Office Visits | 2 | 2019 | 595 | 0.490 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3358 | 0.480 |
Why?
|
Medicaid | 4 | 2021 | 2818 | 0.480 |
Why?
|
Economic Competition | 1 | 2017 | 219 | 0.480 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2015 | 148 | 0.460 |
Why?
|
Hospital Charges | 1 | 2015 | 350 | 0.450 |
Why?
|
Patient Care Management | 1 | 2016 | 302 | 0.440 |
Why?
|
Humans | 98 | 2023 | 761504 | 0.430 |
Why?
|
Cardiology Service, Hospital | 1 | 2015 | 239 | 0.430 |
Why?
|
Specialization | 1 | 2018 | 778 | 0.430 |
Why?
|
Hospitals, Veterans | 1 | 2014 | 395 | 0.400 |
Why?
|
Hospitals | 4 | 2021 | 3882 | 0.400 |
Why?
|
Quality Improvement | 5 | 2021 | 3801 | 0.390 |
Why?
|
Health Services Accessibility | 5 | 2020 | 5440 | 0.390 |
Why?
|
Social Responsibility | 1 | 2014 | 386 | 0.390 |
Why?
|
Diabetes Mellitus | 7 | 2021 | 5840 | 0.380 |
Why?
|
Consumer Health Information | 1 | 2013 | 215 | 0.370 |
Why?
|
Costs and Cost Analysis | 4 | 2021 | 1668 | 0.370 |
Why?
|
Health Services for the Aged | 1 | 2013 | 259 | 0.350 |
Why?
|
Male | 52 | 2021 | 360804 | 0.350 |
Why?
|
Drug Costs | 1 | 2018 | 1183 | 0.330 |
Why?
|
Hospital Costs | 1 | 2015 | 947 | 0.330 |
Why?
|
State Health Plans | 1 | 2011 | 219 | 0.330 |
Why?
|
Confusion | 1 | 2011 | 278 | 0.320 |
Why?
|
Female | 52 | 2021 | 392644 | 0.320 |
Why?
|
Referral and Consultation | 2 | 2019 | 3600 | 0.310 |
Why?
|
Data Collection | 2 | 2015 | 3322 | 0.300 |
Why?
|
Managed Care Programs | 2 | 2013 | 940 | 0.300 |
Why?
|
Patient Satisfaction | 3 | 2021 | 3461 | 0.300 |
Why?
|
Comprehension | 1 | 2013 | 621 | 0.290 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 2024 | 0.290 |
Why?
|
Benchmarking | 4 | 2020 | 1045 | 0.290 |
Why?
|
Budgets | 2 | 2020 | 230 | 0.290 |
Why?
|
Mortality | 4 | 2019 | 2901 | 0.280 |
Why?
|
Preventive Health Services | 3 | 2018 | 567 | 0.280 |
Why?
|
Income | 2 | 2016 | 1877 | 0.280 |
Why?
|
Patient Admission | 4 | 2021 | 1367 | 0.270 |
Why?
|
Terminal Care | 1 | 2018 | 1760 | 0.270 |
Why?
|
Disability Evaluation | 2 | 2017 | 1835 | 0.260 |
Why?
|
Aged, 80 and over | 17 | 2019 | 58976 | 0.250 |
Why?
|
Child Health Services | 1 | 2011 | 646 | 0.250 |
Why?
|
Choice Behavior | 1 | 2011 | 824 | 0.250 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 942 | 0.250 |
Why?
|
Antidepressive Agents | 1 | 2017 | 2897 | 0.240 |
Why?
|
Health Care Reform | 1 | 2014 | 1247 | 0.240 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3085 | 0.240 |
Why?
|
Depressive Disorder | 1 | 2017 | 3728 | 0.230 |
Why?
|
Cardiology | 1 | 2015 | 1656 | 0.230 |
Why?
|
Socioeconomic Factors | 9 | 2021 | 7827 | 0.230 |
Why?
|
Job Satisfaction | 1 | 2008 | 544 | 0.230 |
Why?
|
Linear Models | 4 | 2021 | 5871 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 3245 | 0.220 |
Why?
|
Attitude to Health | 2 | 2013 | 2025 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3205 | 0.210 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3688 | 0.200 |
Why?
|
Arthroplasty, Replacement | 2 | 2020 | 310 | 0.200 |
Why?
|
Workplace | 1 | 2008 | 863 | 0.190 |
Why?
|
Occupational Health | 1 | 2008 | 806 | 0.190 |
Why?
|
Longitudinal Studies | 7 | 2013 | 14605 | 0.190 |
Why?
|
Health Policy | 4 | 2017 | 2684 | 0.180 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3530 | 0.180 |
Why?
|
Critical Care | 1 | 2013 | 2696 | 0.170 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2021 | 166 | 0.170 |
Why?
|
Southeastern United States | 1 | 2020 | 91 | 0.170 |
Why?
|
Arizona | 1 | 2019 | 107 | 0.170 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15500 | 0.170 |
Why?
|
Medicare Part A | 1 | 2019 | 40 | 0.170 |
Why?
|
Personnel Turnover | 1 | 2020 | 88 | 0.170 |
Why?
|
Databases, Factual | 4 | 2016 | 7967 | 0.160 |
Why?
|
Ownership | 2 | 2020 | 339 | 0.160 |
Why?
|
Needs Assessment | 2 | 2016 | 1139 | 0.160 |
Why?
|
Hypertension | 2 | 2017 | 8540 | 0.160 |
Why?
|
Eligibility Determination | 2 | 2013 | 421 | 0.160 |
Why?
|
Middle Aged | 23 | 2021 | 220895 | 0.150 |
Why?
|
Financial Management, Hospital | 1 | 2018 | 70 | 0.150 |
Why?
|
Mental Health | 2 | 2012 | 3250 | 0.140 |
Why?
|
Unnecessary Procedures | 2 | 2019 | 415 | 0.140 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2017 | 78 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 3979 | 0.140 |
Why?
|
Medically Underserved Area | 1 | 2019 | 254 | 0.140 |
Why?
|
Sex Factors | 6 | 2021 | 10552 | 0.140 |
Why?
|
Hospitals, Rural | 1 | 2018 | 176 | 0.130 |
Why?
|
Mental Disorders | 1 | 2016 | 6845 | 0.130 |
Why?
|
Community Health Centers | 1 | 2020 | 461 | 0.130 |
Why?
|
Annual Reports as Topic | 1 | 2015 | 36 | 0.130 |
Why?
|
Medical Oncology | 2 | 2018 | 2321 | 0.130 |
Why?
|
Cognition | 1 | 2013 | 6990 | 0.130 |
Why?
|
Cross-Sectional Studies | 10 | 2021 | 26125 | 0.130 |
Why?
|
Rural Health Services | 1 | 2019 | 384 | 0.130 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2016 | 219 | 0.120 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 623 | 0.120 |
Why?
|
Hematology | 1 | 2018 | 243 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2021 | 846 | 0.110 |
Why?
|
Fees and Charges | 1 | 2015 | 192 | 0.110 |
Why?
|
Risk Management | 1 | 2017 | 558 | 0.110 |
Why?
|
Calcium Channel Blockers | 1 | 2017 | 694 | 0.110 |
Why?
|
Asthma | 1 | 2013 | 6234 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2019 | 728 | 0.110 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 449 | 0.110 |
Why?
|
Drug Prescriptions | 1 | 2003 | 1670 | 0.110 |
Why?
|
Age Factors | 6 | 2021 | 18395 | 0.110 |
Why?
|
Early Detection of Cancer | 2 | 2019 | 3201 | 0.110 |
Why?
|
Medicare Assignment | 1 | 2013 | 9 | 0.110 |
Why?
|
Meningitis, Bacterial | 1 | 2015 | 221 | 0.110 |
Why?
|
Marketing of Health Services | 1 | 2014 | 151 | 0.110 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 1 | 2013 | 92 | 0.110 |
Why?
|
Self Report | 3 | 2020 | 3724 | 0.100 |
Why?
|
Cerebrospinal Fluid | 1 | 2015 | 544 | 0.100 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.100 |
Why?
|
Stress, Psychological | 1 | 2008 | 4481 | 0.100 |
Why?
|
Vulnerable Populations | 1 | 2018 | 703 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 5492 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 695 | 0.100 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.100 |
Why?
|
Ophthalmology | 1 | 2018 | 550 | 0.090 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2017 | 1039 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1516 | 0.090 |
Why?
|
Myocardial Revascularization | 1 | 2014 | 790 | 0.090 |
Why?
|
Adult | 14 | 2021 | 221177 | 0.090 |
Why?
|
Inpatients | 2 | 2021 | 2548 | 0.090 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14666 | 0.080 |
Why?
|
United States Department of Veterans Affairs | 1 | 2014 | 928 | 0.080 |
Why?
|
Metformin | 1 | 2017 | 906 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2021 | 2093 | 0.080 |
Why?
|
Neoplasms | 2 | 2018 | 22170 | 0.080 |
Why?
|
Deductibles and Coinsurance | 1 | 2012 | 316 | 0.080 |
Why?
|
Mental Health Services | 1 | 2021 | 1730 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2021 | 80636 | 0.080 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2019 | 1413 | 0.080 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2019 | 1393 | 0.070 |
Why?
|
Fever | 1 | 2015 | 1618 | 0.070 |
Why?
|
Health Surveys | 2 | 2008 | 4061 | 0.070 |
Why?
|
Maryland | 2 | 2018 | 277 | 0.070 |
Why?
|
Health Benefit Plans, Employee | 1 | 2009 | 333 | 0.070 |
Why?
|
Cohort Studies | 4 | 2021 | 41487 | 0.070 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 1860 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2020 | 5294 | 0.060 |
Why?
|
Health Promotion | 1 | 2018 | 2214 | 0.060 |
Why?
|
Hospital-Patient Relations | 1 | 2005 | 17 | 0.060 |
Why?
|
Psychological Tests | 1 | 2008 | 640 | 0.060 |
Why?
|
Forecasting | 1 | 2015 | 2928 | 0.060 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1069 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.060 |
Why?
|
Risk Assessment | 3 | 2019 | 23995 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3415 | 0.060 |
Why?
|
Models, Organizational | 1 | 2008 | 546 | 0.060 |
Why?
|
Massachusetts | 2 | 2017 | 8830 | 0.060 |
Why?
|
Australia | 1 | 2008 | 1250 | 0.060 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4915 | 0.060 |
Why?
|
Models, Psychological | 1 | 2008 | 828 | 0.060 |
Why?
|
Hospitals, Urban | 1 | 2005 | 500 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2009 | 1315 | 0.050 |
Why?
|
Program Evaluation | 1 | 2011 | 2495 | 0.050 |
Why?
|
Psychometrics | 2 | 2012 | 3065 | 0.050 |
Why?
|
Adolescent | 6 | 2021 | 88319 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
Insurance, Medigap | 1 | 2021 | 21 | 0.050 |
Why?
|
Educational Status | 1 | 2009 | 2522 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8654 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2014 | 2190 | 0.050 |
Why?
|
Cultural Diversity | 1 | 2005 | 369 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 59243 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2005 | 1156 | 0.040 |
Why?
|
Medical Savings Accounts | 1 | 2019 | 34 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2011 | 1852 | 0.040 |
Why?
|
Logistic Models | 3 | 2012 | 13255 | 0.040 |
Why?
|
Rehabilitation | 1 | 2020 | 130 | 0.040 |
Why?
|
Family Characteristics | 1 | 2003 | 1004 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7390 | 0.040 |
Why?
|
Episode of Care | 1 | 2019 | 128 | 0.040 |
Why?
|
Social Support | 1 | 2008 | 2171 | 0.040 |
Why?
|
Arthritis | 1 | 2003 | 680 | 0.040 |
Why?
|
Risk Factors | 3 | 2019 | 74206 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 11118 | 0.040 |
Why?
|
Physician Executives | 1 | 2017 | 134 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2003 | 1141 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12463 | 0.030 |
Why?
|
Case Management | 1 | 2017 | 272 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22176 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10508 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12148 | 0.030 |
Why?
|
Health Behavior | 1 | 2007 | 2643 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15842 | 0.030 |
Why?
|
Aspirin | 1 | 2007 | 3133 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6935 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 2751 | 0.030 |
Why?
|
Research Design | 1 | 2010 | 6180 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 68 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 14031 | 0.030 |
Why?
|
Prescription Drugs | 1 | 2021 | 631 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8481 | 0.030 |
Why?
|
Infant | 2 | 2015 | 36192 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1597 | 0.030 |
Why?
|
Insurance Selection Bias | 1 | 2012 | 69 | 0.030 |
Why?
|
Mammography | 1 | 2003 | 2430 | 0.030 |
Why?
|
Coronary Disease | 1 | 2007 | 5914 | 0.030 |
Why?
|
England | 1 | 2013 | 526 | 0.020 |
Why?
|
Disabled Persons | 1 | 2021 | 1225 | 0.020 |
Why?
|
Medical Informatics | 1 | 2017 | 733 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13380 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2012 | 659 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2019 | 2382 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 42230 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2927 | 0.020 |
Why?
|
Depression | 1 | 2007 | 8124 | 0.020 |
Why?
|
Japan | 1 | 2012 | 1378 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2021 | 3067 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2007 | 11460 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9646 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.020 |
Why?
|
Hospital Departments | 1 | 2005 | 134 | 0.020 |
Why?
|
Models, Statistical | 1 | 2018 | 5079 | 0.010 |
Why?
|
Child | 1 | 2011 | 80153 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2421 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6343 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21353 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15732 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26198 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8708 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39106 | 0.010 |
Why?
|
Boston | 1 | 2005 | 9326 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12059 | 0.010 |
Why?
|